Announcement of Strategic Capital and Business Alliance between TAUNS Laboratories, Inc. and GENEX, Inc.
GENEX begins whole-genome molecular testing service for people concerned about rare, intractable “Nanbyo” diseases – A genetic analysis report to support a physician’s diagnosis is available for less than 40,000 yen –
Genex to begin trusted whole-genome information management services for people with rare diseases, in a first for a private company in Japan – Being a patient-initiated genomic data custodian, Genex will work with physicians to support diagnoses and clinical trials for mitochondrial disease –
We welcome future partners and clients—please write to us using the contact form with your queries/suggestions, and we will get back to you.
Our strategic areas:
in rare diseases